American Diabetes Association (ADA) 86th Scientific Sessions 2026 – Complete Bundle (Videos + ePosters)

Comprehensive Updates in Diabetes, Obesity, Endocrinology, GLP-1 Therapies, Artificial Intelligence, Cardiometabolic Medicine, and Precision Diabetes Care

Stay at the forefront of diabetes research and clinical practice with the American Diabetes Association (ADA) 86th Scientific Sessions 2026 – Complete Bundle, the most comprehensive educational collection from the world’s largest diabetes conference. Featuring more than 200 expert-led educational sessions and over 100 scientific ePosters, this extensive program delivers the latest breakthroughs in diabetes, obesity, endocrinology, metabolism, cardiovascular disease, kidney disease, diabetes technology, and precision medicine.

The ADA 86th Scientific Sessions 2026 brings together internationally recognized clinicians, researchers, endocrinologists, diabetes specialists, scientists, and healthcare professionals to present cutting-edge clinical research, landmark clinical trials, emerging therapies, and evidence-based guidelines that are transforming diabetes prevention and treatment worldwide.

Through symposia, expert panel discussions, late-breaking clinical trials, scientific presentations, and research posters, participants gain practical insights into the newest pharmacologic therapies, artificial intelligence, continuous glucose monitoring, insulin innovations, obesity medicine, cardiovascular risk reduction, chronic kidney disease, metabolic health, and future directions in diabetes care.

Whether you manage patients with Type 1 Diabetes, Type 2 Diabetes, obesity, metabolic syndrome, cardiovascular disease, or endocrine disorders, this comprehensive bundle provides one of the most complete educational resources available in modern diabetes medicine.

Product Details

• Course: ADA 86th Scientific Sessions 2026 – Complete Bundle
• Provider: American Diabetes Association (ADA)
• Conference: ADA 86th Scientific Sessions 2026
• Format: Videos + ePosters (PDF)
• Content Included:
  • 200+ Expert-Led Videos
  • 100+ Scientific ePosters (PDF)
• Language: English
• Educational Level: Intermediate to Advanced

Course Overview

The American Diabetes Association Scientific Sessions represents the premier global scientific meeting dedicated to diabetes, endocrinology, obesity, and metabolic medicine. Each year, leading investigators present the newest discoveries that influence clinical guidelines and shape the future of diabetes care.

The ADA 86th Scientific Sessions 2026 Complete Bundle offers comprehensive access to groundbreaking educational content covering every aspect of diabetes management—from prevention and early diagnosis to advanced therapeutics, technology, precision medicine, and long-term complication management.

Participants explore landmark clinical trials, innovative pharmacologic therapies, next-generation incretin medications, artificial intelligence applications, cardiometabolic disease management, obesity treatment, diabetes technologies, and translational research that can be immediately integrated into clinical practice.

What You’ll Learn

After completing this course, participants will be able to:

• Apply the latest ADA evidence-based recommendations for diabetes management.
• Integrate new GLP-1 receptor agonists and emerging incretin therapies into patient care.
• Evaluate landmark clinical trial results for Type 1 and Type 2 diabetes.
• Optimize cardiovascular, renal, and metabolic outcomes using modern treatment strategies.
• Incorporate artificial intelligence and digital technologies into diabetes care.
• Improve obesity management through pharmacologic and lifestyle interventions.
• Utilize continuous glucose monitoring and diabetes technologies effectively.
• Translate cutting-edge scientific research into daily clinical practice.

Comprehensive Topics Covered

Type 1 Diabetes

Review the latest advances in the diagnosis, treatment, and long-term management of Type 1 Diabetes.

Topics include:

• Adjunctive therapies
• GLP-1/GIP dual agonists
• CT-868 clinical trials
• Insulin optimization
• Continuous glucose monitoring
• Precision medicine

Type 2 Diabetes

Explore evidence-based approaches for improving glycemic control and reducing long-term complications.

Topics include:

• Individualized treatment strategies
• Early intervention
• Combination therapies
• Pharmacologic advances
• Lifestyle management
• Long-term outcomes

GLP-1 Receptor Agonists

Review the newest developments in incretin-based therapies that are reshaping diabetes and obesity treatment.

Topics include:

• GLP-1 receptor agonists
• Emerging therapeutic agents
• Clinical efficacy
• Cardiovascular protection
• Weight reduction
• Future treatment strategies

Faculty review the latest scientific evidence supporting GLP-1 therapy in modern diabetes care.

CagriSema & REIMAGINE Clinical Trials

Gain insight into one of the most anticipated diabetes clinical trial programs.

Topics include:

• REIMAGINE 1
• REIMAGINE 2
• REIMAGINE 3
• CagriSema
• Amylin analogs
• Combination incretin therapy
• Type 2 Diabetes management

Orforglipron (ACHIEVE Program)

Review the emerging era of oral incretin therapies.

Topics include:

• Orforglipron
• ACHIEVE Clinical Trial Program
• Oral GLP-1 therapy
• Treatment innovation
• Patient adherence
• Future therapeutic options

Artificial Intelligence in Diabetes

Explore how AI is transforming diabetes care and clinical decision-making.

Topics include:

• Artificial Intelligence
• Predictive analytics
• Clinical decision support
• Digital health
• Personalized medicine
• Healthcare innovation

Cardiometabolic Medicine

Understand the interconnected management of diabetes, cardiovascular disease, kidney disease, and obesity.

Topics include:

• Cardiovascular risk reduction
• Chronic kidney disease
• Heart failure
• Metabolic syndrome
• Integrated patient care
• Cardiorenal protection

Hypoglycemia Prevention

Review innovative strategies for minimizing hypoglycemia while optimizing glycemic control.

Topics include:

• Hypoglycemia physiology
• Risk assessment
• New therapeutic options
• Technology-assisted prevention
• Clinical management

Obesity Medicine

Learn the newest evidence supporting obesity management as an integral component of diabetes care.

Topics include:

• Obesity pharmacotherapy
• Lifestyle intervention
• Weight management
• Metabolic health
• Precision obesity care

Diabetes Technology

Review rapidly evolving technologies improving diabetes management.

Topics include:

• Continuous glucose monitoring (CGM)
• Smart insulin delivery
• Digital therapeutics
• Connected healthcare
• Wearable technologies

Clinical Trials & Translational Research

Stay current with the latest landmark studies presented at ADA Scientific Sessions.

Topics include:

• Late-breaking clinical trials
• Translational medicine
• Precision endocrinology
• Emerging therapies
• Future research directions

Learning Objectives

Upon completion of this educational activity, participants will be able to:

• Apply current ADA evidence-based recommendations to diabetes management.
• Evaluate new pharmacologic therapies including GLP-1 receptor agonists, oral incretins, and combination therapies.
• Integrate cardiovascular and renal protective strategies into diabetes treatment.
• Utilize diabetes technologies and artificial intelligence to improve patient outcomes.
• Interpret findings from landmark clinical trials and translational research.
• Optimize individualized care for patients with diabetes, obesity, and cardiometabolic disease.

Educational Highlights

• Type 1 Diabetes
• Type 2 Diabetes
• GLP-1 Receptor Agonists
• GIP Agonists
• Amylin Analogues
• CagriSema
• Orforglipron
• ACHIEVE Clinical Trial Program
• Artificial Intelligence
• Diabetes Technology
• Continuous Glucose Monitoring (CGM)
• Cardiometabolic Medicine
• Chronic Kidney Disease
• Obesity Medicine
• Precision Medicine
• Endocrinology
• Clinical Trials
• Scientific ePosters
• Evidence-Based Medicine
• Continuing Medical Education (CME)

Why This Course Stands Out

The ADA 86th Scientific Sessions 2026 – Complete Bundle represents one of the world’s most comprehensive educational resources in diabetes and endocrinology. Combining 200+ educational sessions with 100+ scientific ePosters, the program offers unparalleled access to the latest clinical evidence, landmark research, innovative therapeutics, and future treatment strategies. From next-generation incretin therapies and artificial intelligence to cardiometabolic medicine and obesity management, this bundle equips healthcare professionals with the knowledge needed to deliver state-of-the-art diabetes care.

Target Audience

This educational activity is ideal for:

• Endocrinologists
• Diabetologists
• Internal Medicine Physicians
• Primary Care Physicians
• Obesity Medicine Specialists
• Cardiologists
• Nephrologists
• Hospitalists
• Family Medicine Physicians
• Diabetes Educators
• Nurse Practitioners
• Physician Assistants
• Clinical Pharmacists
• Endocrinology Fellows
• Internal Medicine Residents
• Researchers involved in diabetes and metabolic disease

Why Choose This Course?

Whether you specialize in endocrinology, internal medicine, primary care, cardiology, nephrology, or obesity medicine, the American Diabetes Association 86th Scientific Sessions 2026 – Complete Bundle provides an outstanding evidence-based review of modern diabetes care. Featuring world-renowned experts, groundbreaking clinical trials, innovative therapies, cutting-edge technology, and the latest ADA scientific updates, this program delivers the knowledge needed to improve outcomes for patients with diabetes and cardiometabolic disease.